Back to Search
Start Over
Role of protein kinase C in adriamycin-induced erythroid differentiation of K562 cells.
- Source :
-
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 1991; Vol. 28 (2), pp. 102-4. - Publication Year :
- 1991
-
Abstract
- Modulators of protein kinase C (PKC) were used to investigate the role of this enzyme during Adriamycin-induced erythroid differentiation of K562 cells. Adriamycin (0.1 microM) induced erythroid differentiation in 60% +/- 10% of K562 cells. Phorbol myristate-12-acetate, an activator of protein kinase C, was strongly anti-proliferative to K562 cells (IC50, 8 nM) but did not induce erythroid differentiation. Staurosporine inhibited PKC from K562 cells (IC50, 8 nM) and blocked Adriamycin-induced erythroid differentiation, but only at concentrations marginally below those that inhibited proliferation (IC50, 81 nM), 1-(5-Isoquinolinylsulphonyl)-2-methylpiperazine (H-7) inhibited K562 PKC (IC50, 26 microM) but reduced Adriamycin-induced differentiation by less than 50% at concentrations of up to 600 microM. These data argue against a major role for PKC during Adriamycin-induced erythroid differentiation in K562 cells.
- Subjects :
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Cell Differentiation drug effects
Cell Division drug effects
Cell Line
Culture Techniques
Erythroid Precursor Cells cytology
Erythroid Precursor Cells drug effects
Isoquinolines pharmacology
Piperazines pharmacology
Protein Kinase C physiology
Staurosporine
Tetradecanoylphorbol Acetate pharmacology
Alkaloids pharmacology
Doxorubicin pharmacology
Erythroid Precursor Cells enzymology
Protein Kinase C antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 0344-5704
- Volume :
- 28
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Cancer chemotherapy and pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 2060080
- Full Text :
- https://doi.org/10.1007/BF00689696